Keyphrases
Trypanosoma Cruzi (T. cruzi)
100%
Chagas Disease
100%
Macrophage Activation
100%
Vaccine Effectiveness
100%
Infected Mice
80%
Mitochondrial DNA
60%
Tumor Necrosis Factor-α
60%
Interleukin-10
40%
Macrophages
40%
Interleukin-4 (IL-4)
40%
Tissue Damage
40%
Unvaccinated
40%
Parasite Persistence
40%
Surface Markers
40%
Nitrosative
40%
KDNA
40%
Macrophage Phenotype
40%
18S Ribosomal DNA
40%
T Cells
20%
United States
20%
Inflammatory Cytokines
20%
Emerging Infectious Diseases
20%
DNA Prime
20%
Latin America (LATAM)
20%
Myocarditis
20%
Disease Severity
20%
Clinically Significant
20%
Serum Levels
20%
B Cells
20%
Drug Efficacy
20%
Anti-inflammatory Cytokines
20%
Vaccine Therapy
20%
Effective Treatment
20%
Peripheral Blood
20%
CD8+ T Cells
20%
Inflammatory State
20%
Parasite Burden
20%
Drug Therapy
20%
Cytokine Response
20%
Inflammatory Cytokine Response
20%
Protein Boost
20%
CD16
20%
Challenge Infection
20%
Macrophage Necrosis
20%
Lytic Antibodies
20%
TcDNA
20%
Cardiac Infiltration
20%
Serum Constituents
20%
CD200
20%
CD32
20%
CD206
20%
Immunology and Microbiology
Vaccine Efficacy
100%
Macrophage
100%
Chagas Disease
100%
Vaccine
100%
Tumor Necrosis Factor Alpha
50%
Immunology
50%
Interleukin 4
33%
Interleukin 10
33%
Cytokine Response
33%
Kinetoplast
33%
T Cell
16%
Proinflammatory Cytokine
16%
Infectious Disease
16%
Myocarditis
16%
B Cell
16%
Inflammatory Cytokine
16%
Cytotoxic T-Cell
16%
Trypanosoma Cruzi
16%
Parasite Load
16%
CD16
16%
Blood Level
16%
CD32
16%
CD200
16%